Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 96 articles:
HTML format
Text format



Single Articles


    August 2018
  1. VOLLMAR J, Ch Schmid J, Hoppe-Lotichius M, Barreiros AP, et al
    Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation.
    Transpl Int. 2018 Aug 8. doi: 10.1111/tri.13326.
    PubMed     Text format     Abstract available


    July 2018
  2. GAVRIILIDIS P, Tobias A, Sutcliffe RP, Roberts KJ, et al
    Survival following right lobe split graft, living- and deceased-donor liver transplantation in adult patients: a systematic review and network meta-analysis.
    Transpl Int. 2018 Jul 17. doi: 10.1111/tri.13317.
    PubMed     Text format     Abstract available


  3. JOO DJ, Song SH, Han DH, Park MS, et al
    First Report of a Living Liver Graft in Combined Lung and Liver Transplantation.
    Transpl Int. 2018 Jul 6. doi: 10.1111/tri.13316.
    PubMed     Text format     Abstract available


  4. CASCIATO P, Ambrosi N, Caro F, Vazquez M, et al
    alpha-Lipoic Acid Reduces Post-Reperfusion Syndrome in Human Liver Transplantation - a pilot study.
    Transpl Int. 2018 Jul 5. doi: 10.1111/tri.13314.
    PubMed     Text format     Abstract available


    June 2018
  5. BECKMANN S, Denhaerynck K, Stampf S, Saigi-Morgui N, et al
    New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.
    Transpl Int. 2018 Jun 21. doi: 10.1111/tri.13308.
    PubMed     Text format     Abstract available


  6. GEYER ED, Burrier C, Tumin D, Hayes D Jr, et al
    Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Transpl Int. 2018 Jun 15. doi: 10.1111/tri.13291.
    PubMed     Text format     Abstract available


  7. VINAIXA C, Selzner N, Berenguer M
    Fat and liver transplantation: clinical implications.
    Transpl Int. 2018 Jun 8. doi: 10.1111/tri.13288.
    PubMed     Text format     Abstract available


  8. QUINTINI C, Diago Uso T, Fujiki M, Eghtesad B, et al
    Liver "lobe neutrality" in the era of donor safety. Could "safe" be safer?
    Transpl Int. 2018;31:588-589.
    PubMed     Text format    


    May 2018
  9. SANADA Y, Katano T, Hirata Y, Yamada N, et al
    Interventional radiology treatment for vascular and biliary complications following pediatric living donor liver transplantation.
    Transpl Int. 2018 May 31. doi: 10.1111/tri.13285.
    PubMed     Text format     Abstract available


  10. MAKKI K, Chorasiya V, Srivastava A, Singhal A, et al
    Analysis of caudate lobe biliary anatomy and its implications in living donor liver transplantation - a single centre prospective study.
    Transpl Int. 2018 May 2. doi: 10.1111/tri.13272.
    PubMed     Text format     Abstract available


    April 2018
  11. LOH PS, Gilder F, Klinck J
    Intra-operative cell salvage and sickle cell trait in liver transplantation: time to re-consider?
    Transpl Int. 2018 Apr 19. doi: 10.1111/tri.13268.
    PubMed     Text format     Abstract available


    March 2018
  12. MANZIA TM, Lai Q, Iesari S, Perera MTPR, et al
    Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multi centre cohort study.
    Transpl Int. 2018 Mar 23. doi: 10.1111/tri.13153.
    PubMed     Text format     Abstract available


  13. ANGELICO R, Nardi A, Adam R, Nadalin S, et al
    Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry (ELTR).
    Transpl Int. 2018 Mar 5. doi: 10.1111/tri.13147.
    PubMed     Text format     Abstract available


  14. AGUILERA V, Di Maira T, Conde I, Fornes-Ferrer V, et al
    Cytomegalovirus reactivation in liver transplant recipients due to HCV cirrhosis is associated with higher cardiovascular risk.
    Transpl Int. 2018 Mar 1. doi: 10.1111/tri.13145.
    PubMed     Text format     Abstract available


    February 2018
  15. BLOK JJ, de Boer JD, Putter H, Rogiers X, et al
    The center effect in liver transplantation in the Eurotransplant region.
    Transpl Int. 2018 Feb 6. doi: 10.1111/tri.13129.
    PubMed     Text format     Abstract available


    January 2018
  16. POMMERGAARD HC, Rostved AA, Adam R, Thygesen LC, et al
    Locoregional treatments before liver transplantation for hepatocellular carcinoma: A study from the European Liver Transplant Registry.
    Transpl Int. 2018 Jan 30. doi: 10.1111/tri.13123.
    PubMed     Text format     Abstract available


  17. BIELEN R, Robaeys G, Schelfhout S, Monbaliu D, et al
    Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues for patients at risk for renal failure after liver transplantation.
    Transpl Int. 2018 Jan 23. doi: 10.1111/tri.13112.
    PubMed     Text format     Abstract available


    November 2017
  18. SERPER M, Reese P, Patzer R, Levitsky J, et al
    The Prevalence, Risk Factors, and Outcomes of Medication Tradeoffs in Kidney and Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2017 Nov 25. doi: 10.1111/tri.13098.
    PubMed     Text format     Abstract available


  19. GOET JC, Hansen BE, Tieleman M, van Hoek B, et al
    Current policy for allocation of donor livers in the Netherlands advantages Primary Sclerosing Cholangitis patients on the liver transplantation waiting list - a retrospective study.
    Transpl Int. 2017 Nov 18. doi: 10.1111/tri.13097.
    PubMed     Text format     Abstract available


  20. KARTHIK SV, Quak SH, Aw MM
    Endoscopic retrograde cholangio-pancreatography in the management of biliary complications after Paediatric liver transplantation.
    Transpl Int. 2017 Nov 11. doi: 10.1111/tri.13091.
    PubMed     Text format     Abstract available


  21. LANDI F, de'Angelis N, Sepulveda A, Martinez-Perez A, et al
    Endoscopic treatment of anastomotic biliary stricture after adult deceased donor liver transplantation with multiple plastic stents versus self-expandable metal stents: a systematic review and meta-analysis.
    Transpl Int. 2017 Nov 1. doi: 10.1111/tri.13089.
    PubMed     Text format     Abstract available


    September 2017
  22. VAN VUGT JLA, Buettner S, Alferink LJM, Bossche N, et al
    Low Skeletal Muscle Mass is Associated with Increased Hospital Costs in Patients with Cirrhosis Listed for Liver Transplantation.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13048.
    PubMed     Text format     Abstract available


  23. GILBO N, Van Praet L, Jochmans I, Sainz-Barriga M, et al
    Preoperative Trans-Catheter Arterial Chemo Embolization Increases Hepatic Artery Thrombosis after Liver Transplantation - a retrospective study.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13046.
    PubMed     Text format     Abstract available


    August 2017
  24. QUINTERO J, Juamperez J, Ortega J, Molino JA, et al
    Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients.
    Transpl Int. 2017 Aug 21. doi: 10.1111/tri.13037.
    PubMed     Text format     Abstract available


  25. PEZZATI D, Hassan A, Buccini L, Liu Q, et al
    Liver transplantation with geriatric liver allograft in the US: A matter of epidemiology or of outcome requirements?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13013.
    PubMed     Text format     Abstract available


    July 2017
  26. ARAVINTHAN AAD, Barbas AS, Doyle AC, Tazari M, et al
    Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
    Transpl Int. 2017 Jul 7. doi: 10.1111/tri.13008.
    PubMed     Text format     Abstract available


    June 2017
  27. SATAPATHY SK, Jiang Y, Eason JD, Kedia SK, et al
    Cardiovascular Mortality among Liver Transplant Recipients with Nonalcoholic Steatohepatitis (NASH) in the United States.
    Transpl Int. 2017 Jun 16. doi: 10.1111/tri.13001.
    PubMed     Text format     Abstract available


  28. WHITEHOUSE GP, Hope A, Sanchez-Fueyo A
    Regulatory T Cell Therapy in Liver Transplantation.
    Transpl Int. 2017 Jun 13. doi: 10.1111/tri.12998.
    PubMed     Text format     Abstract available


  29. SALCEDO M, Prieto M, Castells L, Pascasio JM, et al
    Efficacy and safety of daclatasvir-based antiviral therapy in HCV recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multi-centre cohort study.
    Transpl Int. 2017 Jun 13. doi: 10.1111/tri.12999.
    PubMed     Text format     Abstract available


  30. TAKAHASHI K, Nagai S, Puchakayala KG, Safwan M, et al
    Prediction of Biliary Anastomotic Stricture after Deceased Donor Liver Transplantation: The Impact of Platelet Counts.
    Transpl Int. 2017 Jun 12. doi: 10.1111/tri.12996.
    PubMed     Text format     Abstract available


    May 2017
  31. BADAWY A, Hamaguchi Y, Seo S, Kaido T, et al
    Evaluation of Safety of Concomitant Splenectomy in Living Donor Liver Transplantation.
    Transpl Int. 2017 May 17. doi: 10.1111/tri.12985.
    PubMed     Text format     Abstract available


  32. METSELAAR HJ, van den Berg A, Coenraad MJ
    Why we need fairer allocation rules for patients with hepatocellular carcinoma awaiting a liver transplant.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12980.
    PubMed     Text format     Abstract available


    April 2017
  33. ALVER SK, Lorenz DJ, Washburn K, Marvin MR, et al
    Comparison of two equivalent MELD scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12967.
    PubMed     Text format     Abstract available


  34. ALFERINK LJ, Oey RC, Hansen BE, Polak WG, et al
    The impact of infections on delisting patients from the liver transplantation waiting list.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12965.
    PubMed     Text format     Abstract available


  35. YASSEN AM, Elsarraf WR, Elmorshedi MA, Abdel Wahab M, et al
    Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A Prospective Randomized Controlled Trial.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12968.
    PubMed     Text format     Abstract available


  36. PEZZATI D, Ghinolfi D, Lai Q, Cirillo G, et al
    Use of donors with genitourinary malignancies for liver transplantation: A calculated risk?
    Transpl Int. 2017 Apr 8. doi: 10.1111/tri.12962.
    PubMed     Text format     Abstract available


    March 2017
  37. SGARABOTTO D, Fasolato S, Vianello F, Vittadello F, et al
    Antibiotic prophylaxis for preventing post orthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?
    Transpl Int. 2017 Mar 23. doi: 10.1111/tri.12955.
    PubMed     Text format     Abstract available


  38. HARRIES L, Schrem H, Stahmeyer JT, Krauth C, et al
    High Resource Utilization in Liver Transplantation - How Strongly differ Costs between the Care Sectors and What are the Main Cost Drivers?
    Transpl Int. 2017 Mar 11. doi: 10.1111/tri.12950.
    PubMed     Text format     Abstract available


  39. ROLLER J, Glanemann M
    Keep the pressure! Correlation of hemodynamic instability after reperfusion and severity of acute kidney injury following liver transplantation.
    Transpl Int. 2017 Mar 7. doi: 10.1111/tri.12948.
    PubMed     Text format     Abstract available


  40. DE BOER JD, Kopp WH, Ooms K, Haase-Kromwijk BJ, et al
    Abdominal organ procurement in the Netherlands - an analysis of quality and clinical impact.
    Transpl Int. 2017;30:288-294.
    PubMed     Text format     Abstract available


    February 2017
  41. SCHNITZBAUER AA, Bechstein WO
    Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues!
    Transpl Int. 2017 Feb 22. doi: 10.1111/tri.12942.
    PubMed     Text format     Abstract available


  42. GROSSI PA
    Liver Transplantation from donors with positive blood cultures: increased risk of graft failure or opportunity to expand the donor pool?
    Transpl Int. 2017 Feb 20. doi: 10.1111/tri.12939.
    PubMed     Text format     Abstract available


    January 2017
  43. BURRA P, Zanetto A
    Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation.
    Transpl Int. 2017 Jan 19. doi: 10.1111/tri.12917.
    PubMed     Text format     Abstract available


  44. DE BOER JD, Koopman JJ, Metselaar HJ, Braat AE, et al
    Liver transplantation with geriatric liver allografts: the current situation in Eurotransplant.
    Transpl Int. 2017 Jan 6. doi: 10.1111/tri.12914.
    PubMed     Text format     Abstract available


  45. D'AGNOLO HM, Kievit W, van Munster KN, van der Laan JJ, et al
    Center is an important indicator for choice of invasive therapy in polycystic liver disease.
    Transpl Int. 2017;30:76-82.
    PubMed     Text format     Abstract available


    December 2016
  46. HERZER K, Welzel TM, Spengler U, Hinrichsen H, et al
    Real-World Experience With Daclatasvir Plus Sofosbuvir +/- Ribavirin for Post-Liver Transplant HCV Recurrence and Severe Liver Disease.
    Transpl Int. 2016 Dec 24. doi: 10.1111/tri.12910.
    PubMed     Text format     Abstract available


    November 2016
  47. DE MARTIN E, Antonini TM, Coilly A, Pittau G, et al
    HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12898.
    PubMed     Text format     Abstract available


  48. O'LEARY JG, Fontana RJ, Brown K, Burton JR Jr, et al
    Efficacy and Safety of Simeprevir and Sofosbuvir With and Without Ribavirin in Subjects With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant: The Randomized GALAXY Study.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12896.
    PubMed     Text format     Abstract available


  49. HUAMAN MA, Vilchez V, Mei X, Shah MB, et al
    Decreased Graft Survival in Liver Transplant Recipients of Donors with Positive Blood Cultures: A review of the UNOS dataset.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12900.
    PubMed     Text format     Abstract available


  50. KALISVAART M, de Haan JE, Hesselink DA, Polak WG, et al
    The Postreperfusion Syndrome Is Associated With Acute Kidney Injury Following Donation After Brain Death Liver Transplantation.
    Transpl Int. 2016 Nov 19. doi: 10.1111/tri.12891.
    PubMed     Text format     Abstract available


    October 2016
  51. VOUTILAINEN SH, Kosola SK, Tervahartiala TI, Sorsa TA, et al
    Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients.
    Transpl Int. 2016 Oct 23. doi: 10.1111/tri.12879.
    PubMed     Text format     Abstract available


  52. SINGAL AK, Fang X, Kaif M, Hasanin M, et al
    Primary Biliary Cirrhosis Has High Wait List Mortality Among Patients Listed For Liver Transplantation.
    Transpl Int. 2016 Oct 18. doi: 10.1111/tri.12877.
    PubMed     Text format     Abstract available


  53. STINE JG, Argo CK, Pelletier SJ, Maluf DG, et al
    Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.
    Transpl Int. 2016 Oct 6. doi: 10.1111/tri.12855.
    PubMed     Text format     Abstract available


    September 2016
  54. NEVIERE R, Trinh-Duc P, Hulo S, Edme JL, et al
    Predictive value of exhaled nitric oxide and aerobic capacity for sepsis complications after liver transplantion.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12861.
    PubMed     Text format     Abstract available


    August 2016
  55. ROBERTSON FP, Magill LJ, Wright GP, Fuller B, et al
    A systematic review and meta-analysis of donor ischaemic preconditioning in liver transplantation.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12849.
    PubMed     Text format     Abstract available


    July 2016
  56. PAMECHA V, Mahansaria SS, Kumar S, Bharathy KG, et al
    Association of thrombocytopenia with outcome following adult living donor liver transplantation.
    Transpl Int. 2016 Jul 18. doi: 10.1111/tri.12819.
    PubMed     Text format     Abstract available


  57. PITCHAIMUTHU M, Roll GR, Zia Z, Olliff S, et al
    Long-term follow-up after endovascular treatment of hepatic venous outflow obstruction following liver transplantation.
    Transpl Int. 2016 Jul 2. doi: 10.1111/tri.12817.
    PubMed     Text format     Abstract available


    May 2016
  58. BEINHARDT S, Al Zoairy R, Ferenci P, Kozbial K, et al
    DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and post kidney transplantation setting.
    Transpl Int. 2016 May 20. doi: 10.1111/tri.12799.
    PubMed     Text format     Abstract available


  59. TESTINO G
    Alcohol and liver transplantation: the six-month abstinence rule is not a dogma.
    Transpl Int. 2016 May 9. doi: 10.1111/tri.12790.
    PubMed     Text format     Abstract available


    April 2016
  60. LEE KW, Lee S, Dong Kyu O, Na BG, et al
    Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Liver Grafts.
    Transpl Int. 2016 Apr 26. doi: 10.1111/tri.12787.
    PubMed     Text format     Abstract available


  61. BRANDL A, Stolzlechner P, Eschertzhuber S, Aigner F, et al
    Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
    Transpl Int. 2016;29:471-82.
    PubMed     Text format     Abstract available


    March 2016
  62. TIAN Y, Lesurtel M, Ungethuem U, Song Z, et al
    A novel technique in mouse liver transplantation (with video).
    Transpl Int. 2016 Mar 31. doi: 10.1111/tri.12780.
    PubMed     Text format     Abstract available


  63. IJTSMA AJ, van der Hilst CS, Nijkamp DM, Bottema JT, et al
    Does The MELD System Provide Equal Access to Liver Transplantation for Patients with Different ABO Blood Groups?
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12774.
    PubMed     Text format     Abstract available


    February 2016
  64. KOLLMANN D, Rasoul-Rockenschaub S, Steiner I, Freundorfer E, et al
    Good outcome after liver transplantation for ALD without a 6-months abstinence rule prior to transplantation including post-transplant CDT-monitoring for alcohol relapse assessment - a retrospective study.
    Transpl Int. 2016 Feb 10. doi: 10.1111/tri.12756.
    PubMed     Text format     Abstract available


  65. ELDEEN FZ, Mourad MM, Bhandari M, Roll G, et al
    Accepting multiple simultaneous liver offers does not negatively impact transplant outcomes.
    Transpl Int. 2016;29:227-33.
    PubMed     Text format     Abstract available


    January 2016
  66. KIVELA JM, Kosola S, Perasaari J, Makisalo H, et al
    Donor-specific antibodies after pediatric liver transplantation: a cross-sectional study of 50 patients.
    Transpl Int. 2016 Jan 25. doi: 10.1111/tri.12747.
    PubMed     Text format     Abstract available


  67. ZHONG Z, Ye S, Xiong Y, Wu L, et al
    Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway.
    Transpl Int. 2016;29:98-107.
    PubMed     Text format     Abstract available


  68. PANDANABOYANA S, Longbotham D, Hostert L, Attia M, et al
    Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Transpl Int. 2016;29:73-80.
    PubMed     Text format     Abstract available


    December 2015
  69. RODRIGUEZ-PERALVAREZ M, Rico-Juri JM, Tsochatzis E, Burra P, et al
    Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12737.
    PubMed     Text format     Abstract available


  70. RUSSO FP, Zanetto A, Burra P
    Timing for treatment of HCV recurrence after liver transplantation: the earlier the better.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12739.
    PubMed     Text format     Abstract available


  71. LIESE J, Peveling-Oberhag J, Doering C, Schnitzbauer AA, et al
    A possible role of miRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation.
    Transpl Int. 2015 Dec 23. doi: 10.1111/tri.12733.
    PubMed     Text format     Abstract available


  72. GAMBATO M, Crespo G, Torres F, LLovet L, et al
    Simple prediction of long-term clinical outcomes in patients with mild hepatitis c recurrence after liver transplantation.
    Transpl Int. 2015 Dec 11. doi: 10.1111/tri.12730.
    PubMed     Text format     Abstract available


    November 2015
  73. ROBERTSON FP, Bessell PR, Diaz-Nieto R, Thomas N, et al
    High serum Aspartate Transaminase (AST) levels on day 3 post liver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12723.
    PubMed     Text format     Abstract available


  74. LIBRIZZI S, Guadalix S, Martinez-Diaz Guerra G, Allo G, et al
    Trabecular bone sc0re in patients with liver transplants after one year of risedronate treatment.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12725.
    PubMed     Text format     Abstract available


    October 2015
  75. DARWISH MURAD S, Metselaar HJ
    The invasion of fatty liver disease in liver transplantation.
    Transpl Int. 2015 Oct 24. doi: 10.1111/tri.12707.
    PubMed     Text format     Abstract available


    September 2015
  76. ALKHOURI N, Hanouneh IA, Zein NN, Lopez R, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in Young Patients.
    Transpl Int. 2015 Sep 24. doi: 10.1111/tri.12694.
    PubMed     Text format     Abstract available


    August 2015
  77. ARRIZZA C, De Gottardi A, Foglia E, Baumgartner M, et al
    Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up.
    Transpl Int. 2015 Aug 27. doi: 10.1111/tri.12677.
    PubMed     Text format     Abstract available


  78. BELLO AD, Congy-Jolivet N, Danjoux M, Muscari F, et al
    De novo Donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients.
    Transpl Int. 2015 Aug 25. doi: 10.1111/tri.12654.
    PubMed     Text format     Abstract available


  79. O'LEARY JG
    Donor-specific alloantibodies in liver transplantation: How should we define and improve long-term success?
    Transpl Int. 2015 Aug 18. doi: 10.1111/tri.12661.
    PubMed     Text format     Abstract available


  80. UEDA Y, Uemoto S
    Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation.
    Transpl Int. 2015 Aug 13. doi: 10.1111/tri.12653.
    PubMed     Text format     Abstract available


    July 2015
  81. BURRA P, De Martin E, Zanetto A, Senzolo M, et al
    "HCV and liver transplantation: where do we stand?"
    Transpl Int. 2015 Jul 21. doi: 10.1111/tri.12642.
    PubMed     Text format     Abstract available


  82. BHAT M, Hathcock M, Kremers WK, Darwish Murad S, et al
    Portal Vein Encasement Predicts Neoadjuvant Therapy Response in Liver Transplantation for Perihilar Cholangiocarcinoma protocol.
    Transpl Int. 2015 Jul 16. doi: 10.1111/tri.12640.
    PubMed     Text format     Abstract available


  83. SPETZLER VN, Goldaracena N, Kaths JM, Marquez M, et al
    High Pre-operative Bilirubin Values Protect Against Reperfusion Injury after Live Donor Liver Transplantation.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12634.
    PubMed     Text format     Abstract available


  84. LEVESQUE E, Paugam-Burtz C, Saliba F, Khoy-Ear L, et al
    Fungal complications after Candida preservation fluid contamination in liver-transplant recipients.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12633.
    PubMed     Text format     Abstract available


  85. HOUBEN P, Manzini G, Kremer M, Arend J, et al
    Graft rinse prior to reperfusion in liver transplantation: Literature review and online survey within the Eurotransplant community.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12631.
    PubMed     Text format     Abstract available


  86. THOMAS MN, Nadalin S, Schemmer P, Pascher A, et al
    A German survey of the abdominal transplantation surgical work force.
    Transpl Int. 2015;28:849-56.
    PubMed     Text format     Abstract available


  87. HALDAR D, Chen F, Byron J, Elsharkawy AM, et al
    Is it time to revisit contraindications to organ donation from donors with a JAK-2 mutation? Safe use of a liver allograft from a donor with essential thrombocythaemia.
    Transpl Int. 2015;28:881-3.
    PubMed     Text format     Abstract available


    June 2015
  88. BONACCI M, Londono MC, Esforzado N, Forns X, et al
    Antiviral Treatment with Sofosbuvir and Simeprevir in a Kidney-Transplant Recipient with HCV-Decompensated Cirrhosis: Viral Eradication and Removal from the Liver Transplant Waiting List.
    Transpl Int. 2015 Jun 13. doi: 10.1111/tri.12622.
    PubMed     Text format     Abstract available


  89. UCHIDA H, Fukuda A, Sasaki K, Miyasaka M, et al
    Donor Double Common Bile Duct in Living Donor Liver Transplantation.
    Transpl Int. 2015 Jun 5. doi: 10.1111/tri.12619.
    PubMed     Text format     Abstract available


    May 2015
  90. BHATTI AB, Dar FS, Zia H
    Where Angels Fear to Tread: Donor Bile Duct Division in Living Donor Liver Transplant.
    Transpl Int. 2015 May 27. doi: 10.1111/tri.12613.
    PubMed     Text format     Abstract available


  91. KURAMITSU K, Fukumoto T, Yano Y, Hirano H, et al
    A case of intravascular lymphoma diagnosed in an explanted liver after liver transplantation.
    Transpl Int. 2015 May 23. doi: 10.1111/tri.12611.
    PubMed     Text format     Abstract available


    March 2015
  92. WESTERKAMP AC, de Boer MT, van den Berg AP, Gouw AS, et al
    Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Transpl Int. 2015;28:319-29.
    PubMed     Text format     Abstract available


    February 2015
  93. WATT KD
    Is 40 the new 30?
    Transpl Int. 2015;28:146-7.
    PubMed     Text format    


  94. TRIPON S, Francoz C, Albuquerque A, Paradis V, et al
    Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia.
    Transpl Int. 2015;28:162-9.
    PubMed     Text format     Abstract available


    August 2014
  95. INDOLFI G, Berczes R, Pelliccioli I, Bosisio M, et al
    Neonatal haemochromatosis with reversible pituitary involvement.
    Transpl Int. 2014;27:e76-9.
    PubMed     Text format     Abstract available


    May 2014
  96. ALMEIDA-PAULO GN, Lubomirov R, Alonso-Sanchez NL, Espinosa-Roman L, et al
    Limited Sampling Strategies For Tacrolimus Exposure (Auc ) Prediction After Prograf And Advagraf Administration In Children And Adolescents With Liver Or Kidney Transplants.
    Transpl Int. 2014 May 27. doi: 10.1111/tri.12362.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: